ʻO ka lāʻau pale SARS-CoV-2 IgM/IgG

Kiʻi Hoʻohanohano no ka lāʻau pale SARS-CoV-2 IgM/IgG

Wehewehe Pōkole:

Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o ka antibody SARS-CoV-2 IgG i loko o nā hāpana kanaka o ka serum/plasma, ke koko venous a me ke koko manamana lima, me ka antibody SARS-CoV-2 IgG i loko o nā heluna kanaka i loaʻa i ka maʻi kūlohelohe a me nā heluna kanaka i pale ʻia me ka lāʻau pale.

E leka uila mai iā mākou

Nā kikoʻī huahana

Nā Lepili Huahana

Inoa huahana

Pahu ʻIke Antibody HWTS-RT090-SARS-CoV-2 IgM/IgG (ʻano gula Colloidal)

Palapala hōʻoia

ʻAlapia

ʻO ka maʻi Coronavirus 2019 (COVID-19), he maʻi pneumonia ia i hoʻokumu ʻia e ka maʻi me kahi coronavirus hou i kapa ʻia ʻo Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2). ʻO SARS-CoV-2 kahi coronavirus hou ma ka genus β a maʻalahi ke kanaka i ka SARS-CoV-2. ʻO nā kumu nui o ka maʻi ʻo ia nā poʻe maʻi COVID-19 i hōʻoia ʻia a me ka mea lawe asymptomatic o SARS-CoV-2. Ma muli o ka noiʻi epidemiological o kēia manawa, ʻo ka manawa incubation he 1-14 mau lā, ʻo ka hapa nui he 3-7 mau lā. ʻO nā hōʻike nui he kuni, ka ʻū maloʻo, a me ka luhi. He helu liʻiliʻi o nā poʻe maʻi e hele pū me ka ihu paʻa, ka ihu wai, ka ʻeha ʻāʻī, ka myalgia a me ka diarrhea.

Nā Palena ʻenehana

ʻĀpana i manaʻo ʻia	ʻO ka lāʻau pale SARS-CoV-2 IgM/IgG
Mahana mālama	4℃-30℃
ʻAno laʻana	ʻO ke koko kanaka, ka plasma, ke koko venous a me ke koko manamana lima
Ola papa	24 mahina
Nā mea hana kōkua	ʻAʻole koi ʻia
Nā Mea Hoʻopau Keu	ʻAʻole koi ʻia
Ka manawa ʻike	10-15 minuke
Kūlana kikoʻī	ʻAʻohe hopena kea me nā pathogens, e like me Human coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, novel influenza A (H1N1) influenza virus (2009), seasonal H1N1 influenza virus, H3N2, H5N1, H7N9, influenza B virus Yamagata, Victoria, respiratory syncytial virus A a me B, parainfluenza virus type 1,2,3, Rhinovirus A, B, C, adenovirus type 1,2,3,4,5,7,55.